Market Research Logo

Global Glioma Therapeutics Market Analysis & Trends - Industry Forecast to 2027

Global Glioma Therapeutics Market Analysis & Trends - Industry Forecast to 2027

The Global Glioma Therapeutics Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include Advances in Glioblastoma Multiforme Treatment, Rise in Patient Population and Expedited Drug Discovery Process and Decrease in development of drug cost.

Based on Product, the market is categorized into Small molecules and Biologics.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia Pacific

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- South Africa
- Others

Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
- Market opportunities and recommendations for new investments


1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Advances in Glioblastoma Multiforme Treatment
3.1.2 Rise in Patient Population and Expedited Drug Discovery Process
3.1.3 Decrease in development of drug cost
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Glioma Therapeutics Market, By Product
4.1 Small molecules
DATA TABLE Small molecules Market Forecast to 2027 (US$ MN)
4.2 Biologics
DATA TABLE Biologics Market Forecast to 2027 (US$ MN)
5 Glioma Therapeutics Market, By Geography
5.1 North America
DATA TABLE North America Market Forecast by Countries to 2027 (US$ MN)
5.1.1 US
5.1.2 Canada
5.1.3 Mexico
5.2 Europe
DATA TABLE Europe Market Forecast by Countries to 2027 (US$ MN)
5.2.1 France
5.2.2 Germany
5.2.3 Italy
5.2.4 Spain
5.2.5 UK
5.2.6 Rest of Europe
5.3 Asia Pacific
DATA TABLE Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 Australia
5.3.5 New Zealand
5.3.6 Rest of Asia Pacific
5.4 Middle East
DATA TABLE Middle East Market Forecast by Countries to 2027 (US$ MN)
5.4.1 Saudi Arabia
5.4.2 UAE
5.4.3 Rest of Middle East
5.5 Latin America
DATA TABLE Latin America Market Forecast by Countries to 2027 (US$ MN)
5.5.1 Argentina
5.5.2 Brazil
5.5.3 Rest of Latin America
5.6 Rest of the World (RoW)
DATA TABLE Rest of the World (RoW) Market Forecast by Countries to 2027 (US$ MN)
5.6.1 South Africa
5.6.2 Others
6 Key Player Activities
6.1 Mergers & Acquisitions
6.2 Partnerships, Joint Venture’s, Collaborations and Agreements
6.3 Product Launch & Expansions
6.4 Other Activities
7 Leading Companies
7.1 F. Hoffmann-La Roche
7.2 Merck Sharp & Dohme
7.3 Mylan
7.4 NextSource Biotechnology
7.5 Novartis
List of Tables
Table 1 Global Glioma Therapeutics Market By Region, Market Forecast (2015-2027) (US$ MN)
Table 2 Global Glioma Therapeutics Market By Product, Market Forecast (2015-2027) (US$ MN)
Table 3 Global Glioma Therapeutics Market By Small molecules, Market Forecast (2015-2027) (US$ MN)
Table 4 Global Glioma Therapeutics Market By Biologics, Market Forecast (2015-2027) (US$ MN)
Table 5 North America Glioma Therapeutics Market By Country, Market Forecast (2015-2027) (US$ MN)
Table 6 North America Glioma Therapeutics Market By Product, Market Forecast (2015-2027) (US$ MN)
Table 7 North America Glioma Therapeutics Market By Small molecules, Market Forecast (2015-2027) (US$ MN)
Table 8 North America Glioma Therapeutics Market By Biologics, Market Forecast (2015-2027) (US$ MN)
Table 9 Europe Glioma Therapeutics Market By Country, Market Forecast (2015-2027) (US$ MN)
Table 10 Europe Glioma Therapeutics Market By Product, Market Forecast (2015-2027) (US$ MN)
Table 11 Europe Glioma Therapeutics Market By Small molecules, Market Forecast (2015-2027) (US$ MN)
Table 12 Europe Glioma Therapeutics Market By Biologics, Market Forecast (2015-2027) (US$ MN)
Table 13 Asia Pacific Glioma Therapeutics Market By Country, Market Forecast (2015-2027) (US$ MN)
Table 14 Asia Pacific Glioma Therapeutics Market By Product, Market Forecast (2015-2027) (US$ MN)
Table 15 Asia Pacific Glioma Therapeutics Market By Small molecules, Market Forecast (2015-2027) (US$ MN)
Table 16 Asia Pacific Glioma Therapeutics Market By Biologics, Market Forecast (2015-2027) (US$ MN)
Table 17 Middle East Glioma Therapeutics Market By Country, Market Forecast (2015-2027) (US$ MN)
Table 18 Middle East Glioma Therapeutics Market By Product, Market Forecast (2015-2027) (US$ MN)
Table 19 Middle East Glioma Therapeutics Market By Small molecules, Market Forecast (2015-2027) (US$ MN)
Table 20 Middle East Glioma Therapeutics Market By Biologics, Market Forecast (2015-2027) (US$ MN)
Table 21 Latin America Glioma Therapeutics Market By Country, Market Forecast (2015-2027) (US$ MN)
Table 22 Latin America Glioma Therapeutics Market By Product, Market Forecast (2015-2027) (US$ MN)
Table 23 Latin America Glioma Therapeutics Market By Small molecules, Market Forecast (2015-2027) (US$ MN)
Table 24 Latin America Glioma Therapeutics Market By Biologics, Market Forecast (2015-2027) (US$ MN)
Table 25 Rest of the World (RoW) Glioma Therapeutics Market By Country, Market Forecast (2015-2027) (US$ MN)
Table 26 Rest of the World (RoW) Glioma Therapeutics Market By Product, Market Forecast (2015-2027) (US$ MN)
Table 27 Rest of the World (RoW) Glioma Therapeutics Market By Small molecules, Market Forecast (2015-2027) (US$ MN)
Table 28 Rest of the World (RoW) Glioma Therapeutics Market By Biologics, Market Forecast (2015-2027) (US$ MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report